196 related articles for article (PubMed ID: 9662508)
1. TGF-beta-signaling with small molecule FKBP12 antagonists that bind myristoylated FKBP12-TGF-beta type I receptor fusion proteins.
Stockwell BR; Schreiber SL
Chem Biol; 1998 Jul; 5(7):385-95. PubMed ID: 9662508
[TBL] [Abstract][Full Text] [Related]
2. Probing the role of homomeric and heteromeric receptor interactions in TGF-beta signaling using small molecule dimerizers.
Stockwell BR; Schreiber SL
Curr Biol; 1998 Jun; 8(13):761-70. PubMed ID: 9651680
[TBL] [Abstract][Full Text] [Related]
3. FKBP12 is not required for the modulation of transforming growth factor beta receptor I signaling activity in embryonic fibroblasts and thymocytes.
Bassing CH; Shou W; Muir S; Heitman J; Matzuk MM; Wang XF
Cell Growth Differ; 1998 Mar; 9(3):223-8. PubMed ID: 9543388
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of TGFbeta receptor inhibition by FKBP12.
Chen YG; Liu F; Massague J
EMBO J; 1997 Jul; 16(13):3866-76. PubMed ID: 9233797
[TBL] [Abstract][Full Text] [Related]
5. The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type I receptors.
Wang T; Li BY; Danielson PD; Shah PC; Rockwell S; Lechleider RJ; Martin J; Manganaro T; Donahoe PK
Cell; 1996 Aug; 86(3):435-44. PubMed ID: 8756725
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells.
Bourguignon LY; Singleton PA; Zhu H; Zhou B
J Biol Chem; 2002 Oct; 277(42):39703-12. PubMed ID: 12145287
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the interaction of FKBP12 with the transforming growth factor-beta type I receptor in vivo.
Okadome T; Oeda E; Saitoh M; Ichijo H; Moses HL; Miyazono K; Kawabata M
J Biol Chem; 1996 Sep; 271(36):21687-90. PubMed ID: 8702959
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta receptor type I-dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1/2 pathways.
Pannu J; Nakerakanti S; Smith E; ten Dijke P; Trojanowska M
J Biol Chem; 2007 Apr; 282(14):10405-13. PubMed ID: 17317656
[TBL] [Abstract][Full Text] [Related]
9. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
[TBL] [Abstract][Full Text] [Related]
10. Identification of important regions in the cytoplasmic juxtamembrane domain of type I receptor that separate signaling pathways of transforming growth factor-beta.
Saitoh M; Nishitoh H; Amagasa T; Miyazono K; Takagi M; Ichijo H
J Biol Chem; 1996 Feb; 271(5):2769-75. PubMed ID: 8576253
[TBL] [Abstract][Full Text] [Related]
11. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P
Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129
[TBL] [Abstract][Full Text] [Related]
12. FKBP12 is a negative regulator of transforming growth factor-beta receptor internalization.
Yao D; Doré JJ; Leof EB
J Biol Chem; 2000 Apr; 275(17):13149-54. PubMed ID: 10777621
[TBL] [Abstract][Full Text] [Related]
13. Functional conservation of Schistosoma mansoni Smads in TGF-beta signaling.
Beall MJ; McGonigle S; Pearce EJ
Mol Biochem Parasitol; 2000 Nov; 111(1):131-42. PubMed ID: 11087923
[TBL] [Abstract][Full Text] [Related]
14. A chimeric serine/threonine kinase receptor system reveals the potential of multiple type II receptors to cooperate with transforming growth factor-beta type I receptor.
Muramatsu M; Yan J; Eto K; Tomoda T; Yamada R; Arai K
Mol Biol Cell; 1997 Mar; 8(3):469-80. PubMed ID: 9188099
[TBL] [Abstract][Full Text] [Related]
15. CHIP controls the sensitivity of transforming growth factor-beta signaling by modulating the basal level of Smad3 through ubiquitin-mediated degradation.
Xin H; Xu X; Li L; Ning H; Rong Y; Shang Y; Wang Y; Fu XY; Chang Z
J Biol Chem; 2005 May; 280(21):20842-50. PubMed ID: 15781469
[TBL] [Abstract][Full Text] [Related]
16. FK506 binding protein 12 mediates sensitivity to both FK506 and rapamycin in murine mast cells.
Fruman DA; Wood MA; Gjertson CK; Katz HR; Burakoff SJ; Bierer BE
Eur J Immunol; 1995 Feb; 25(2):563-71. PubMed ID: 7533090
[TBL] [Abstract][Full Text] [Related]
17. IGFBP-3 activates TGF-beta receptors and directly inhibits growth in human intestinal smooth muscle cells.
Kuemmerle JF; Murthy KS; Bowers JG
Am J Physiol Gastrointest Liver Physiol; 2004 Oct; 287(4):G795-802. PubMed ID: 15178549
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta receptor expression and binding in rat mesangial cells: modulation by glucose and cyclic mechanical strain.
Riser BL; Ladson-Wofford S; Sharba A; Cortes P; Drake K; Guerin CJ; Yee J; Choi ME; Segarini PR; Narins RG
Kidney Int; 1999 Aug; 56(2):428-39. PubMed ID: 10432381
[TBL] [Abstract][Full Text] [Related]
19. A novel protein distinguishes between quiescent and activated forms of the type I transforming growth factor beta receptor.
Charng MJ; Zhang D; Kinnunen P; Schneider MD
J Biol Chem; 1998 Apr; 273(16):9365-8. PubMed ID: 9545258
[TBL] [Abstract][Full Text] [Related]
20. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling.
Hanyu A; Ishidou Y; Ebisawa T; Shimanuki T; Imamura T; Miyazono K
J Cell Biol; 2001 Dec; 155(6):1017-27. PubMed ID: 11739411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
